O’Melveny represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the IPO.Qyuns Therapeutics Co., Ltd. (2509.HK) announced its…
Qyuns Therapeutics’ US$31 Million Initial Public Offering
